David Dl Bowtell

14PUBLICATIONS
288CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursPostcolonial studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 06, 2026
Using polygenic risk scores to refine risk and outcomes in high-grade serous ovarian cancer in Australia.

|Feb 26, 2025
Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes.

Lindsay J Collin, Kara L Cushing-Haugen, Kathryn L Terry

|Jun 05, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.

Flurina A M Saner, Kazuaki Takahashi, Timothy Budden

|Jun 20, 2023
The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas.

Karolin Heinze, Evan S Cairns, Shelby Thornton

|Feb 15, 2023
Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma.

Chen Wang, Matthew S Block, Julie M Cunningham

|Feb 02, 2023
CCNE1 Amplification as a Therapeutic Target.

George Au-Yeung, Linda Mileshkin, David D L Bowtell

Pageof 3

Frequent Collaborators

8 joint publications

Anna DeFazio

7 joint publications

Susan J Ramus

7 joint publications

Dale W Garsed

7 joint publications

Sian Fereday